Details of the Drug
General Information of Drug (ID: DMABLF7)
| Drug Name |
PT-104
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
149488-13-1; Thiourea, N-(5-bromo-2-pyridinyl)-N'-(2-(2,6-difluorophenyl)ethyl)-; Thiourea, N-(5-bromo-2-pyridinyl)-N'-[2-(2,6-difluorophenyl)ethyl]-; PT-104; PETT Analog 57; PETT deriv. 21; AC1MHDJX; LY300046HCl Analog 1; CHEMBL88677; BDBM1890; SCHEMBL6905477; DTXSID00164313; ZINC3832005; 1-(2,6-Difluorophenethyl)-3-(5-bromo-2-pyridinyl)thiourea; 1-(5-bromo-2-pyridyl)-3-[2-(2,6-difluorophenyl)ethyl]thiourea; 3-(5-bromopyridin-2-yl)-1-[2-(2,6-difluorophenyl)ethyl]thiourea; N-(2-(2,6-Difluorophenyl)ethyl)-N -(2-(5-bromopyri
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 372.23 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


